About this trial

Prospective, observational study to define precipitants and predictors of development of Acute-on-Chronic Liver Failure (ACLF) after surgical interventions, allowing to develop a risk stratification for elective procedures in cirrhotic patients. As well as identifying molecular mechanisms of post-interventional ACLF and thus preparing the ground for development of new therapeutic approaches.

Eligibility criteria

Qualifiers

Male or female adult (≥18 years) patient

With or without liver cirrhosis (diagnosed either histologically or by a combination of clinical, laboratory and radiological signs)

Or Non-cirrhotic portal hypertension

Non-pregnant, non-lactating females

Disqualifiers

Pregnant or lactating females

Patients undergoing surgery as form of palliative cancer therapy

Presence or history of severe extra-hepatic diseases

HIV-positive patients

Trial design

Treatments tested in this trial

  • No Intervention

Treatment groups

200 Participants
are divided into 1 treatment group

Locations

1
University Hospital Bonn Bonn Germany

Sponsors and collaborators

University Hospital, Bonn

Lead sponsor